World’s First Integrated Imaging Service for Long Covid approved by UK’s MHRA. Read more.
We deliver digital technologies that help clinicians to provide better care for patients with liver disease.
Our diverse and talented team is united behind our vision to empower patients and clinicians through a greater understanding of liver disease, enabling early detection, diagnosis and targeted treatment.
Patients are at the heart of our design. Our technology is convenient, non-invasive and supports patient engagement in their care by providing clear and understandable results.
Perspectum® was founded in partnership with the University of Oxford in 2012 after a ground-breaking study demonstrated the potential of T1 mapping to predict liver fibrosis.
New ways of accurately diagnosing liver disease early are essential if health care systems are to tackle this growing issue, which is predicted to lead to many more cases of serious liver damage and people needing liver transplants.
Our work focuses on the detection and accurate, quantitative measurement of liver, gallbladder and pancreatic disease, including precancerous and cancerous states.
More about us
Led by a dynamic and inspirational team, we are leading the way in delivering digital technologies that help clinicians to deliver better care for people with liver disorders.
Find out more about the people behind the technology.
Looking to invest?
Medtech companies are at the vanguard in developing innovative technologies that optimize medical diagnostics and procedures that reduce risk and cost. Investment in medical device technology has led to many people living longer, healthier and more independent lives.
At Perspectum we are dedicated to continually developing our technology and services to improve outcomes for patients and aid clinicians in faster diagnosis.
If you would like to be a part of our story and invest in Perspectum then please get in touch.Contact us